And the winner of Startup Battlefield at Disrupt 2026 is: Intero Biosystems

{"#Intero Biosystems":"Intero Biosystems, founded by Charlie Childs and Madeline Eiken, spun out of the University of Michigan. The company focuses on developing 1mm human intestinal 'organoids,' lab-grown tissue that mimics the gut. This technology offers a new way to study how drugs and other compounds might affect the human body before they are tested in people. The startup sells its flagship product, GastroScreen, to pharmaceutical, biotech, food, and chemical companies for testing drugs and other compounds. The company's success at TechCrunch Disrupt 2026 underscores the potential of this innovative technology.","#GastroScreen":"GastroScreen is a product that allows companies to test drugs and other compounds on lab-grown human intestinal tissue. This technology could revolutionize drug testing and research by providing a more accurate and ethical alternative to animal testing.","#Startup Battlefield":"The Startup Battlefield at TechCrunch Disrupt 2026 is a competition where startups pitch their ideas to a panel of judges. Intero Biosystems was one of the top 20 startups selected to compete, and their success in this competition highlights the potential of their GastroScreen product."}